search
Back to results

Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Haemorrhage Following Caesarean Section

Primary Purpose

Bleeding, Anemia

Status
Completed
Phase
Phase 4
Locations
Egypt
Study Type
Interventional
Intervention
Pabal 100 mcg iv infusion over 1 minute given after delivery of fetal head
Oxytocin 5 IU iv infusion and Methtergine 0.2 mg iv
Sponsored by
Beni-Suef University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Bleeding focused on measuring Postpartum hemorrhage, Cesarean section, Uterotonics

Eligibility Criteria

20 Years - 30 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • • Women with a singleton pregnancy undergoing elective cesarean section after 37 weeks of gestation.

Exclusion Criteria:

  • Women undergoing cesarean section with general anesthesia will be excluded, because carbetocin is licensed for use with regional anaesthesia only.
  • women undergoing cesarean section at less than 37 weeks of gestation (likely to be emergency cesarean sections; a different smaller group from term pregnancies)
  • Hypertension with pregnancy.
  • Cardiac and coronary diseases with pregnancy

Sites / Locations

  • Nesreen Abdel Fattah Abdullah Shehata

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Pabal ( carbetocin)

Oxytocin and Methergine (methyl ergometrine)

Arm Description

Pabal (carbetocin which is a long acting oxytocin ) given as 100 mcg slow i.v. injection over 1 minute ( Draxis/Multiph). It will be given to the patients included in the study after delivery of the fetal head.

The second group of patients included in the study will be given Oxytocin 5 IU ampoule by intravenous infusion and Methergine 0.2 mg IV after delivery of fetal head.

Outcomes

Primary Outcome Measures

Uterine tone and size
The uterine tone and size will be assessed by using a hand resting on the fundus and palpating the anterior wall of the uterus one hour after the operation. The presence of a boggy uterus with either heavy vaginal bleeding or increasing uterine size can suspect diagnosis of uterine atony.

Secondary Outcome Measures

Blood loss
Blood loss will be estimated postoperatively by giving each woman of each group standard 2 dressings (standard weight of dressing is 25 gm) for one hour postoperative and recording weight of blood soaked dressings and volume of lost blood.

Full Information

First Posted
March 29, 2014
Last Updated
April 9, 2015
Sponsor
Beni-Suef University
search

1. Study Identification

Unique Protocol Identification Number
NCT02101567
Brief Title
Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Haemorrhage Following Caesarean Section
Official Title
A Comparison Between Carbetocin, Oxytocin and Ergometrine in Prevention of Postpartum Haemorrhage Following Caesarean Section
Study Type
Interventional

2. Study Status

Record Verification Date
April 2015
Overall Recruitment Status
Completed
Study Start Date
May 2014 (undefined)
Primary Completion Date
April 2015 (Actual)
Study Completion Date
April 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Beni-Suef University

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The investigators compare the effectiveness and adverse effects of I.V carbetocin versus oxytocin & ergometrine I.V for prevention of postpartum haemorrhage following cesarean section.
Detailed Description
Postpartum hemorrhage (PPH) accounts for nearly one quarter of all maternal deaths worldwide 1 and was the second most frequent cause of maternal death in the UK for the 2000-2002 triennium. Caesarean section is a recognized risk factor for PPH and the worldwide caesarean delivery rate is increasing .2 A combination of oxytocin and ergometrine is effective in preventing postpartum hemorrhage but is frequently associated with side effects such as retained placenta and hypertension. A recent guideline on PPH prevention developed by the World Health Organization recommended the use of oxytocin for prevention of PPH in settings in which active management of labor is not practiced. Ergometrine is an ergot alkaloid and hypertension and cardiac disease are contraindications due to the possible development of severe hypertension and myocardial ischemia. Carbetocin is a newly developed uterotonics and it may represent a promising choice as reported in the literature. It is a synthetic analogue of human oxytocin with structural modifications that increase its half-life thereby prolonging its pharmacological effects . A prospective double blinded randomized study . The study population will include 200 patients. The study will take place in Beni_suef University Hospitals. Inclusion criteria: • Women with a singleton pregnancy undergoing elective caesarean section after 37 weeks of gestation. Exclusion criteria Women undergoing cesarean section with general anesthesia will be excluded, because carbetocin is licensed for use with regional anaesthesia only. women undergoing cesarean section at less than 37 weeks of gestation (likely to be emergency cesarean sections; a different smaller group from term pregnancies) Hypertension with pregnancy. Cardiac and coronary diseases with pregnancy Women included in the study were divided into 2 groups: .Group (A): including 100 patients who will receive carbetocin 100 µg I.V after delivery of the fetal head. .Group (B): including 100 patients who will receive a combination of intraoperative oxytocin 5 I.U & ergometrine 0.2 mg.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bleeding, Anemia
Keywords
Postpartum hemorrhage, Cesarean section, Uterotonics

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
200 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Pabal ( carbetocin)
Arm Type
Active Comparator
Arm Description
Pabal (carbetocin which is a long acting oxytocin ) given as 100 mcg slow i.v. injection over 1 minute ( Draxis/Multiph). It will be given to the patients included in the study after delivery of the fetal head.
Arm Title
Oxytocin and Methergine (methyl ergometrine)
Arm Type
Active Comparator
Arm Description
The second group of patients included in the study will be given Oxytocin 5 IU ampoule by intravenous infusion and Methergine 0.2 mg IV after delivery of fetal head.
Intervention Type
Drug
Intervention Name(s)
Pabal 100 mcg iv infusion over 1 minute given after delivery of fetal head
Other Intervention Name(s)
Carbetocin
Intervention Description
In the first group of patients, carbitocin 100 mcg will be given iv infusion over one minute after delivery of the head in cesarean section.
Intervention Type
Drug
Intervention Name(s)
Oxytocin 5 IU iv infusion and Methtergine 0.2 mg iv
Other Intervention Name(s)
Oxytocin and Methyl ergometrine
Intervention Description
In the second group of patients oxytocin 5 IU will be given iv infusion and Methergine 0.2 mg iv
Primary Outcome Measure Information:
Title
Uterine tone and size
Description
The uterine tone and size will be assessed by using a hand resting on the fundus and palpating the anterior wall of the uterus one hour after the operation. The presence of a boggy uterus with either heavy vaginal bleeding or increasing uterine size can suspect diagnosis of uterine atony.
Time Frame
One hour after the cesarean section
Secondary Outcome Measure Information:
Title
Blood loss
Description
Blood loss will be estimated postoperatively by giving each woman of each group standard 2 dressings (standard weight of dressing is 25 gm) for one hour postoperative and recording weight of blood soaked dressings and volume of lost blood.
Time Frame
One hour after cesarean section
Other Pre-specified Outcome Measures:
Title
Hemoglobin concentration
Description
Changes in hemoglobin concentrations before and 24 hours postoperative. Using a 10% fall in hematocrit value to define post-partum hemorrhage.
Time Frame
Before and 24 hours after the operation

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
30 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: • Women with a singleton pregnancy undergoing elective cesarean section after 37 weeks of gestation. Exclusion Criteria: Women undergoing cesarean section with general anesthesia will be excluded, because carbetocin is licensed for use with regional anaesthesia only. women undergoing cesarean section at less than 37 weeks of gestation (likely to be emergency cesarean sections; a different smaller group from term pregnancies) Hypertension with pregnancy. Cardiac and coronary diseases with pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nesreen A Shehata, MD
Organizational Affiliation
Beni-Suef University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Nesreen Abdel Fattah Abdullah Shehata
City
Cairo
Country
Egypt

12. IPD Sharing Statement

Links:
URL
http://www.ncbi.nlm.nih.gov/pubmed/?term=Carroli+et+al.%2C+2008
Description
Epidemiology of postpartum haemorrhage: a systematic review. Carroli G1, Cuesta C,2008 Dec;22(6):999-1012. doi: 10.1016/j.bpobgyn.2008.08.004. Epub 2008 Sep 25. Abalos E, Gulmezoglu AM.
URL
http://www.ncbi.nlm.nih.gov/pubmed/?term=Villar+JWojdylaC+Zavaleta+NC+Carroli+Velazco+Aetal.Cessarean+delivery+rates+and+pregnancy+outcomes%3A+the+2005+WHO+global+survey+on+maternal+and+perinatal+health+in+
Description
• Villar J, Valladares E, Wojdyla D, Zavaleta N, Carroli G, Velazco A, et al. Caesarean delivery rates and pregnancy outcomes: the 2005 WHO global survey on maternal and perinatal health in Latin America. Lancet 2006; 367:1819-29.

Learn more about this trial

Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Haemorrhage Following Caesarean Section

We'll reach out to this number within 24 hrs